Atlas Trials

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Clinical trial NCT06550076 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06550076
Sponsor
Takeda
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Plaque Psoriasis
Start date
2024-09-04
Primary completion
2029-08-05
Enrollment
2099

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.